Hefni, D. et al. 2022. Tetraprenyltoluquinone Inhibits the Tumor Marker Aldo-Keto Reductase: An in Silico Study. International Journal on Advanced Science, Engineering and Information Technology. 12, 6 (Dec. 2022), 2532–2536. DOI:https://doi.org/10.18517/ijaseit.12.6.16596.